Cabergoline diphosphate

Preparation Note Prepared by a modification of the procedure of Sowdon, J.C.

Preparation Note Prepared by a modification of the procedure of Sowdon, J.C.

Application 8-Bromoadenosine 3&#8242,5&#8242-cyclic monophosphate has been used: to treat H295R cells as positive controls for CYP19 induction as a membrane permeable cAMP analog to study its effect on short-circuit current ( I sc ) to

Application 8-Bromoadenosine 3&#8242,5&#8242-cyclic monophosphate has been used: to treat H295R cells as positive controls for CYP19 induction as a membrane permeable cAMP analog to study its effect on short-circuit current ( I sc ) to

Application 8-Bromoadenosine 3&#8242,5&#8242-cyclic monophosphate has been used: to treat H295R cells as positive controls for CYP19 induction as a membrane permeable cAMP analog to study its effect on short-circuit current ( I sc ) to

Anti-LPAR6 lysophosphatidic acid receptor 6, 100ul UN 1687 6

Anti-LPAR6 lysophosphatidic acid receptor 6, 100ul UN 1687 6

Anti-LPAR6 lysophosphatidic acid receptor 6, 25ul UN 1687 6.

Application Diphenyl phosphate can be used as an organic catalyst for the ring-opening polymerization (ROP) of renewable 5-alkyl &#948-lactones. In combination with zinc iodide, it forms a novel initiating system for the living cationic

Application Diphenyl phosphate can be used as an organic catalyst for the ring-opening polymerization (ROP) of renewable 5-alkyl &#948-lactones. In combination with zinc iodide, it forms a novel initiating system for the living cationic

Amino Acid Sequence Cer-Glc-Gal(NeuAc)-GalNAc General description Ganglioside GM2 (GM2), a monosialic ganglioside, belongs to the group of glycosphingolipids that are mostly localized to the outer leaflet of the plasma membrane. Gangliosides are

A cell-permeable, bioavailable nicotinamide derivative that acts as a highly potent, ATP-competitive multi-kinase inhibitor (IC 50 = 2, 3, 6, 8 nM for VEGFR1, VEGFR2, VEGFR3, and Kit, respectively). Also inhibits the activity of PDGFR and RET